V A Boussiotis
Overview
Explore the profile of V A Boussiotis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
3473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kourtis A, Pangalis G, Borche L, Boussiotis V, Dighiero G, Lymberi P
Leuk Lymphoma
. 2016 Jul;
5(4):255-62.
PMID: 27467848
Sera from 60 patients with non-Hodgkin's lymphomas (NHL) were tested by isoelectric focusing (IEF) and immunoblotting (IB) techniques for the presence of monoclonal or oligoclonal immunoglobulins (Ig). Of the 60...
2.
Kittas C, Korkolopoulou P, Pangalis G, Tsenga A, Boussiotis V, Spandidos D
Leuk Lymphoma
. 2016 Jul;
1(3-4):241-7.
PMID: 27463992
The expression of c-myc oncogene in neoplastic and non-neoplastic lymphoid tissue was studied using the specific monoclonal antibody myc 1-9E10 and the 3 step streptavidin-biotin immunoperoxidase method in paraffin sections....
3.
Panaytotidis P, Boussiotis V, Pangallis G
Leuk Lymphoma
. 2016 Jul;
1(3-4):235-40.
PMID: 27463991
The immune function of seventeen previously untreated stage A, B-chronic lymphocytic leukemia (B-CLL) patients receiving α2b-interferon (α2b-IFN) was studied before therapy and three months later. In eleven patients a decrease...
4.
Lugassy G, Boussiotis V, Ruchlemer R, Pangalis G, Berrebi A, Polliack A
Leuk Lymphoma
. 2016 Jul;
5 Suppl 1:179-82.
PMID: 27463503
We describe six rare patients with B-type CLL under the age of 30 years. All were males and four showed a relatively aggressive clinical course requiring initial chemotherapy at an...
5.
Pangalis G, Reverter J, Boussiotis V, Montserrat E
Leuk Lymphoma
. 2016 Jul;
5 Suppl 1:175-8.
PMID: 27463502
Whether all younger adult patients with chronic lymphocytic leukemia (CLL) should be offered intensive and/or experimental treatments is currently undecided. In order to investigate the natural history and prognosis of...
6.
Boussiotis V, Panayiotidis P, Pangalis G
Leuk Lymphoma
. 2016 Jul;
5 Suppl 1:113-7.
PMID: 27463491
In the present study we investigated whether prolonged intermittent chlorambucil (Chl) administration is more effective for B-chronic lymphocytic leukemia (B-CLL) patients, compared to the traditional mode of shorter duration. One...
7.
Li L, Kim H, Nellore A, Patsoukis N, Petkova V, McDonough S, et al.
Blood Cancer J
. 2014 Jan;
4:e178.
PMID: 24442207
The outcome of umbilical cord blood transplantation (UCBT) is compromised by low hematopoietic stem cell (HSC) doses leading to prolonged time to engraftment, delayed immunological reconstitution and late memory T-cell...
8.
Cutler C, Stevenson K, Kim H, Brown J, McDonough S, Herrera M, et al.
Bone Marrow Transplant
. 2010 Aug;
46(5):659-67.
PMID: 20697368
The main limitations to umbilical cord blood (UCB) transplantation (UCBT) in adults are delayed engraftment, poor immunological reconstitution and high rates of non-relapse mortality (NRM). Double UCBT (DUCBT) has been...
9.
Cardoso B, Martins L, Santos C, Nadler L, Boussiotis V, Cardoso A, et al.
Leukemia
. 2008 Jul;
23(1):206-8.
PMID: 18596736
No abstract available.
10.
Vassilakopoulos T, Angelopoulou M, Siakantaris M, Kontopidou F, Dimopoulou M, Barbounis A, et al.
Eur J Haematol
. 2002 Mar;
67(5-6):279-88.
PMID: 11872075
Background: Advanced Hodgkin's lymphoma (HL) is curable by conventional chemotherapy in 60--70% of patients. The pretreatment identification of a sizeable subgroup of patients with sufficiently low failure-free survival (FFS) to...